Alan Daugherty Selected Research

Bone Marrow Transplantation (Transplantation, Bone Marrow)

9/2014	Deficiency of the NR4A orphan nuclear receptor NOR1 in hematopoietic stem cells accelerates atherosclerosis.
12/2011	Urokinase-type plasminogen activator deficiency in bone marrow-derived cells augments rupture of angiotensin II-induced abdominal aortic aneurysms.
2/2009	G2A deficiency in mice promotes macrophage activation and atherosclerosis.
2/2007	Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alan Daugherty Research Topics

Disease

91	Atherosclerosis 01/2023 - 01/2002
69	Abdominal Aortic Aneurysm 01/2024 - 03/2003
23	Inflammation (Inflammations) 01/2024 - 02/2002
19	Aneurysm (Aneurysms) 01/2023 - 03/2003
19	Hypercholesterolemia 01/2023 - 12/2004
18	Aortic Aneurysm (Aneurysm, Aortic) 01/2023 - 05/2010
18	Rupture 10/2020 - 08/2006
14	Aortic Rupture 10/2023 - 08/2005
12	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 06/2002
12	Body Weight (Weight, Body) 01/2023 - 01/2003
10	Thoracic Aortic Aneurysm 10/2021 - 01/2010
9	Ascending Aorta Aneurysm 12/2021 - 04/2008
8	Obesity 01/2018 - 10/2009
7	Hypertension (High Blood Pressure) 12/2023 - 02/2008
6	Sepsis (Septicemia) 01/2021 - 07/2009
6	Vascular Diseases (Vascular Disease) 02/2019 - 04/2004
5	Aortic Dissection 01/2022 - 09/2003
5	Atherosclerotic Plaque (Atheroma) 01/2021 - 02/2008
5	Thrombosis (Thrombus) 01/2019 - 02/2002
3	Fatty Liver 01/2023 - 02/2016
3	Hyperlipidemias (Hyperlipidemia) 01/2021 - 02/2002
2	Vascular Remodeling 01/2023 - 10/2017
2	Infections 12/2022 - 01/2016
2	Hemorrhage 01/2022 - 06/2006
2	COVID-19 10/2020 - 06/2020
2	Dyslipidemias (Dyslipidemia) 01/2020 - 08/2015
2	Hyperplasia 09/2015 - 02/2010
2	Hypertrophy 10/2012 - 02/2010

Drug/Important Bio-Agent (IBA)

78	Angiotensin IIIBA 12/2023 - 03/2003
33	Apolipoproteins E (ApoE)IBA 01/2023 - 06/2002
29	LDL Receptors (LDL Receptor)IBA 01/2023 - 03/2002
23	Lipoproteins (Lipoprotein)IBA 10/2019 - 01/2002
19	ApolipoproteinsIBA 11/2023 - 02/2002
17	CholesterolIBA 01/2022 - 05/2002
13	AngiotensinogenIBA 04/2024 - 12/2004
12	LipidsIBA 01/2023 - 06/2003
11	CytokinesIBA 01/2021 - 09/2005
10	AngiotensinsIBA 01/2023 - 12/2004
8	ReninIBA 12/2023 - 03/2008
7	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2012
6	Losartan (Cozaar)FDA LinkGeneric 01/2023 - 07/2013
6	LigandsIBA 10/2021 - 10/2004
6	Phenobarbital (Luminal)FDA Link 02/2019 - 02/2002
5	Peptides (Polypeptides)IBA 12/2023 - 12/2004
5	Angiotensin-Converting Enzyme 2IBA 10/2020 - 04/2011
5	LDL Lipoproteins (beta Lipoproteins)IBA 01/2020 - 03/2002
5	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2012 - 09/2005
4	Antisense OligonucleotidesIBA 01/2023 - 01/2016
4	Pancreatic Elastase (Elastase)IBA 01/2023 - 01/2021
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 12/2006
4	oxidized low density lipoproteinIBA 01/2018 - 06/2004
4	Matrix Metalloproteinases (MMPs)IBA 05/2017 - 03/2003
4	Messenger RNA (mRNA)IBA 01/2012 - 01/2005
3	ElastinIBA 01/2024 - 07/2013
3	AminopropionitrileIBA 10/2023 - 01/2022
3	Proprotein Convertase 9IBA 12/2022 - 01/2016
3	Type 1 Angiotensin ReceptorIBA 10/2022 - 10/2012
3	Transcription Factors (Transcription Factor)IBA 11/2021 - 09/2014
3	Triglycerides (Triacylglycerol)IBA 01/2021 - 03/2009
3	SaltsIBA 01/2020 - 07/2013
3	Angiotensin IIBA 01/2020 - 09/2013
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2020 - 09/2013
3	AldosteroneIBA 01/2018 - 02/2005
3	Glucose (Dextrose)FDA LinkGeneric 05/2015 - 01/2011
3	HDL LipoproteinsIBA 05/2014 - 07/2009
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2013 - 09/2007
3	Interferon-gamma (Interferon, gamma)IBA 01/2009 - 02/2002
3	Interleukin-4 (Interleukin 4)IBA 12/2007 - 03/2002
2	Serine Proteases (Serine Protease)IBA 12/2022 - 10/2020
2	RNA (Ribonucleic Acid)IBA 10/2022 - 12/2021
2	Fibrillin-1IBA 10/2021 - 05/2019
2	Prorenin ReceptorIBA 01/2021 - 01/2018
2	Low Density Lipoprotein Receptor-Related Protein-2IBA 01/2020 - 01/2019
2	Amino Acids FDA Link 01/2020 - 01/2019
2	LipopolysaccharidesIBA 01/2019 - 01/2013
2	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2018 - 07/2013
2	Acetates (Acetic Acid Esters)FDA Link 01/2018 - 07/2013
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2018 - 05/2017
2	Desoxycorticosterone (Deoxycorticosterone)IBA 01/2018 - 07/2013
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2017 - 08/2010
2	Testosterone (Sustanon)FDA Link 01/2017 - 05/2012
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2017 - 01/2016
2	aliskiren FDA Link 02/2016 - 03/2008
2	Renin InhibitorsIBA 02/2016 - 03/2008
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 05/2015 - 02/2014
2	salicylhydroxamic acid (SHAM)IBA 03/2015 - 08/2004
2	Orphan Nuclear ReceptorsIBA 09/2014 - 08/2010
2	Scavenger Receptors (Scavenger Receptor)IBA 05/2014 - 07/2009
2	Enalapril FDA LinkGeneric 09/2013 - 07/2013
2	Spironolactone (Aldactone)FDA LinkGeneric 07/2013 - 02/2005
2	Interleukin-6 (Interleukin 6)IBA 03/2013 - 01/2013
2	SmokeIBA 09/2012 - 06/2010

Therapy/Procedure

10	Therapeutics 01/2021 - 02/2008
5	Ligation 01/2021 - 07/2009
4	Punctures 01/2021 - 07/2009
4	Bone Marrow Transplantation (Transplantation, Bone Marrow) 09/2014 - 02/2007
3	Subcutaneous Infusions 09/2015 - 04/2008
2	Intraperitoneal Injections 01/2021 - 01/2013
2	Castration 03/2015 - 07/2008
2	Operative Surgical Procedures 01/2015 - 10/2012